Measures to address medical inflation could soften revenue, but issues have abated significantly: IHH Healthcare
CEO says group is now negotiating directly with insurers, offering more packages and discounts
[SINGAPORE] IHH Healthcare will likely face “some softening” in patient admissions and revenue from the measures the group has implemented to combat medical inflation in Malaysia, but the situation has “improved considerably”, said its group chief executive Prem Nair on Friday (May 30).
The group is now negotiating directly with insurers, offering more packages and discounts, he said. Issues that triggered the medical inflation issue, such as a weak ringgit, have “abated significantly”.
“(Medical inflation) has not fully gone away, but we have all now come to the table,” said Dr Nair, noting that the group is also in discussions about medical inflation with parties such as Malaysia’s health ministry and life insurance association.
TRENDING NOW
What’s wrong with Orchard Road? Experts weigh in on the street’s cachet and its future
CSE Global independent director quits after clashes with chairman Eugene Lai over board refresh
Onitsuka Tiger pivots from Asics stripes to tap luxury market
Singapore to advance AI agenda as Asean chair, focus on cross-border data flows, smaller firms